Shilajit for Energy and Fatigue After Menopause. The Mitochondrial Research.

Quick answer: The persistent, unrefreshing fatigue that appears at menopause is partly a mitochondrial problem. Estrogen supported the production and efficiency of the mitochondria in your cells, the structures that turn food and oxygen into usable energy. When estrogen signaling falls, that efficiency drops. The fulvic acid in shilajit works on the same system. This article covers the mechanism, what the animal and human research has found, and where the honest limits of the evidence sit.

The fatigue that sleep does not fix

There is a specific kind of tiredness that many women describe in the years around menopause. It is not the tired from a hard day. It is a background heaviness that does not lift after a full night of sleep. Standing up feels heavier. Concentration wanders. Things that used to feel effortless now cost something.

This is not imagined and it is not depression, though it is often confused with both.

Part of the explanation sits inside the cells themselves, in the mitochondria.

What estrogen was doing for your energy all along

Mitochondria are the structures inside cells that produce ATP, the chemical your body actually runs on. Everything from muscle contraction to brain function to temperature regulation uses ATP as fuel. Mitochondria produce it by running a process called oxidative phosphorylation, which requires oxygen and uses an electron transport chain to do the conversion.

Estrogen was involved in this process in ways most people never hear about.

Estrogen is an activator of PGC-1 alpha, a master regulator of mitochondrial biogenesis, the process by which cells produce new mitochondria. More mitochondria mean more ATP-producing capacity. Estrogen also supports the efficiency of the mitochondria that already exist, influencing how well the electron transport chain runs.

When estrogen signaling drops at menopause, two things happen at the cellular energy level. Cells produce fewer new mitochondria. And the ones they have run less efficiently. The result is reduced ATP output for the same input. Persistent fatigue is, in part, a downstream symptom of that shift.

What the fulvic acid in shilajit does

The fulvic acid in shilajit has been studied for its role in the same mitochondrial system.

Fulvic acid functions as an electron shuttle. In the mitochondrial electron transport chain, electrons are passed between carrier molecules as part of the energy conversion process. Fulvic acid can participate in that electron transfer, acting as what biochemists call a redox-active molecule. By supporting the flow of electrons through the chain, it helps the mitochondria run the ATP production process more efficiently.

Fulvic acid also works alongside CoQ10, a coenzyme the body produces naturally and uses in the same electron transport chain. Research has shown that shilajit helps preserve CoQ10 in the tissues where the mitochondria are most active, particularly in the heart and liver. CoQ10 declines with age, and its decline is one of the reasons mitochondrial efficiency drops in older adults.

This is not a stimulant mechanism. There is no caffeine in shilajit. There is no adrenaline signal, no blood pressure spike, no cortisol push. The energy support comes from working on the efficiency of a cellular process that is already running, not by forcing the nervous system to speed up.

The animal fatigue study

The most direct research on shilajit and fatigue comes from an animal model of chronic fatigue syndrome.

Surapaneni and colleagues in 2012 induced a chronic fatigue state in rats through repeated forced swimming and then treated one group with shilajit. The research was published in the Journal of Ethnopharmacology.

The results were across three layers.

First, behavioral fatigue reversed. The shilajit-treated animals showed significantly less fatigue behavior than the control group.

Second, mitochondrial enzyme activity was preserved. The enzymes that run the electron transport chain in muscle tissue, specifically succinate dehydrogenase and malate dehydrogenase, were maintained at higher levels in the shilajit group. These enzymes are direct measures of how actively the mitochondria are working.

Third, mitochondrial membrane potential was maintained. Mitochondrial membrane potential is the electrical gradient across the mitochondrial membrane that drives ATP synthesis. When it collapses, energy production stops. The shilajit group maintained that gradient while the control group lost it.

This is an animal study. Direct conclusions about human postmenopausal fatigue cannot be drawn from rat chronic fatigue research. But the study is showing shilajit acting exactly where the mechanism predicts it should act, on the mitochondrial machinery itself.

The human evidence, with honest flags

There are two human trials on shilajit and physical fatigue or endurance. Both have important limitations that need to be named clearly.

An 8-week randomized controlled trial by Keller and colleagues in 2019 enrolled 63 physically active men and gave them 500 mg of shilajit daily or placebo. The primary finding was that the shilajit group preserved maximum muscle strength after a fatiguing protocol better than the placebo group. Hydroxyproline, a marker of connective tissue breakdown, also fell.

This is a randomized controlled trial, which is the right study design. The population is the limitation. These were physically active men, not postmenopausal women, and the study was measuring performance in a specific fatiguing context, not the background chronic fatigue of hormonal change. The result is directionally useful but cannot be applied directly to menopausal fatigue.

A 2026 open-label pilot by Yadav and colleagues enrolled 25 healthy men over 28 days of shilajit supplementation at 500 mg daily. Leg-press strength, endurance, and aerobic capacity all rose. Markers of fatigue and inflammation fell.

The limitations here are significant. No placebo group, small sample, men only. Open-label studies are susceptible to expectation effects. Read this as directional evidence only.

Neither trial was designed for postmenopausal women, and that is a real gap in the current research. The mechanism from the animal data, and the shilajit literature overall, consistently points toward mitochondrial support. The human fatigue evidence exists. It just has not been tested in the population where the mechanism would predict the clearest benefit.

Steady energy, not a spike

The way shilajit works matters for women who have already been through the stimulant cycle.

A lot of the fatigue remedies on the market work by pushing the nervous system, caffeine, B12 injections at high doses, adaptogens dosed for an acute response. They produce energy by forcing a stress signal. That is why they work for an hour and then require more. They are not fixing the cellular machinery. They are making the machinery run hotter for a window.

Shilajit does not work that way. The mechanism is at the cellular level, not the nervous system level. The mitochondria run more efficiently. More ATP gets produced from the same substrate. The experience of that is not a surge. It is a steadier baseline, less of the heaviness that creeps in by mid-afternoon, less of the recovery cost from ordinary days.

Women who take shilajit for the first time often describe it as feeling less like their energy went up and more like the drag went away. That is what cellular energy support actually feels like when it works.

The week-one expectation

One thing worth setting clearly before any supplement for fatigue. The mitochondrial system does not change overnight.

The animal research showed reversal of fatigue markers, but across a repeated treatment protocol. The human trials ran eight weeks and 28 days respectively. The bone mineral density trial ran 48 weeks.

Week one, nothing happened. The women in the bone trial did not feel their bones getting stronger at day seven. The mechanism was running, but the output was not yet measurable. Week one of shilajit for energy works the same way. The fulvic acid is beginning to support the electron transport chain, and the CoQ10 preservation is building. The felt shift usually starts to appear in weeks three and four. The full steadying usually takes longer.

This is what real mitochondrial support looks like. It earns its results in a way that a stimulant spike never can.

Safety

Across every human clinical study on shilajit, zero serious adverse events have been reported. A 91-day high-dose safety study in animals at up to 5,000 mg per kilogram showed no organ toxicity, no unusual changes in iron levels, and normal histology. Human therapeutic doses are a fraction of that ceiling.

Shilajit does contain naturally occurring minerals from the rock resin, which is part of the mechanism. Purity testing matters because the geological source can also concentrate unwanted trace metals in unpurified material. Optimum shilajit comes from the Altai mountains, cold-pressed and purified, and every batch is independently tested by a third-party laboratory for heavy metals, mycotoxins, and Prop 65 compliance. We are a small, family-owned company out of Florida.

What this means for you

If the fatigue you are dealing with does not respond to more sleep, fewer commitments, or the usual caffeine patch, the cellular energy level is worth looking at as a root cause.

The mitochondrial picture at menopause is real. Estrogen supported those structures throughout your reproductive years. Its absence changes the energy equation at the cell level, not just at the hormone level. Addressing that requires something that works on the same system.

Shilajit and the fulvic acid in it have been studied against that system, in mechanism research, in animal fatigue models, and in human performance trials. The honest picture is that the strongest evidence comes from the animal and mechanism work, the human trials have important limitations, and the postmenopausal-women-specific trial does not yet exist. What does exist is a consistent mechanistic picture pointing in the same direction.

The Optimum Shilajit Trifecta combines purified shilajit from the Altai mountains with pearl powder and bamboo silica in a formula designed for women over 50. You can find it at https://www.liveoptimum.co/products/optimum-shilajit-trifecta.

Frequently asked questions

Why does energy drop so much after menopause?

Fatigue after menopause has several roots, but the mitochondrial one is underexplored. Estrogen supported the production of new mitochondria in cells and the efficiency of the ones already there. When estrogen signaling falls, cells produce less ATP, the chemical your body runs on. This shows up as the persistent, unrefreshing tiredness that more sleep does not fix.

Does shilajit boost energy?

The research shows shilajit works on the cellular machinery behind energy production, not by stimulating the nervous system. In an animal model of chronic fatigue, shilajit reversed behavioral fatigue, preserved mitochondrial enzyme activity, and maintained mitochondrial membrane potential. Human trials in men showed preserved muscle strength after fatigue and improved aerobic capacity. Those trials did not include postmenopausal women, which is a real limitation of the current evidence.

How does shilajit affect mitochondria?

The fulvic acid in shilajit functions as an electron shuttle in the mitochondrial electron transport chain, the process that converts food and oxygen into ATP. It also helps preserve CoQ10, the coenzyme the body uses in that same chain. The result is more efficient cellular energy production rather than a stimulant spike.

Is shilajit a stimulant?

No. Shilajit contains no caffeine and does not work through adrenergic mechanisms. It works at the mitochondrial level, supporting the efficiency of cellular energy production rather than pushing the nervous system. The shift in energy tends to feel steady rather than a spike followed by a crash.

Is shilajit safe for long-term use?

Across every human clinical study on shilajit, zero serious adverse events have been reported. A 91-day high-dose safety study in animals found no organ toxicity at doses far above the human therapeutic range. Optimum shilajit is third-party tested for heavy metals and mycotoxins and comes from the Altai mountains.

References

1. Surapaneni DK, et al. Shilajit attenuates behavioral symptoms of chronic fatigue syndrome by modulating the hypothalamic-pituitary-adrenal axis and mitochondrial bioenergetics in rats. Journal of Ethnopharmacology. 2012;143(1):91-99. https://pubmed.ncbi.nlm.nih.gov/22771318/
2. Keller JL, et al. The effects of Shilajit supplementation on fatigue-induced decreases in muscular strength and serum hydroxyproline levels. Journal of the International Society of Sports Nutrition. 2019;16:3. https://pubmed.ncbi.nlm.nih.gov/30728074/
3. Yadav AK, et al. Shilajit resin supplementation improves physical performance in healthy adult males. 2026. https://pubmed.ncbi.nlm.nih.gov/41613504/
4. Velmurugan C, et al. Safety and toxicological study of black shilajit after 91-day repeated dosing in albino rats. Asian Pacific Journal of Tropical Biomedicine. 2012. https://pmc.ncbi.nlm.nih.gov/articles/PMC3609271/
5. Stohs SJ, et al. A review of the efficacy and safety of Shilajit (Mumie, Moomiyo). Phytotherapy Research. 2014. https://pubmed.ncbi.nlm.nih.gov/23733436/